BEIJING -- Triastek, a Chinese startup using 3D technology to develop medicines, has raised about 100 million yuan ($15 million) in a Series A+ funding round.
36Kr/KrASIA
Chinese maker of 3D-printed drugs secures $15m in funding
Startup Triastek has already filed patent applications in Japan and the US
